HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 19, 19936-19947, May 7, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/19/19936    most recent M309304200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sriram, K. Articles by O'Callaghan, J. P. Search for Related Content PubMed PubMed Citation Articles by Sriram, K. Articles by O'Callaghan, J. P. Social Bookmarking                      What's this?

Induction of gp130-related Cytokines and Activation of JAK2/STAT3 Pathway in Astrocytes Precedes Up-regulation of Glial Fibrillary Acidic Protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Neurodegeneration

KEY SIGNALING PATHWAY FOR ASTROGLIOSIS IN VIVO?^*

Krishnan Sriram, Stanley A. Benkovic, Meleik A. Hebert, Diane B. Miller, and James P. O'Callaghan

From the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505

Reactive gliosis is a hallmark of disease-, trauma-, and chemical-induced damage to the central nervous system. The signaling pathways associated with this response to neural injury remain to be elucidated, but recent evidence implicates the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway. Here, we used the known dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to selectively damage striatal dopaminergic nerve terminals and elicit a glial response. We then analyzed changes in gene expression and protein phosphorylation, in vivo, to identify ligands and mediators of the JAK-STAT pathway that accompany glial activation. Administration of MPTP caused rapid tyrosine (Tyr-705) phosphorylation and nuclear translocation of STAT3 in striatal astrocytes, prior to the induction of glial fibrillary acidic protein mRNA and protein. Pharmacological protection of dopaminergic nerve terminals with nomifensine abolished MPTP-mediated phosphorylation and translocation of STAT3 and prevented induction of astrogliosis. Among the Janus kinase family of tyrosine kinases, only JAK2 was associated with the phosphorylation of STAT3 after MPTP and, inhibition of JAK2 by AG490, in vivo, attenuated both the phosphorylation of STAT3 and induction of GFAP. The p44/42 mitogen-activated protein kinase (MAPK; ERK1/2) also was activated by MPTP, but was not associated with activation of STAT3, because serine (Ser-727) was not phosphorylated. The mRNA for ligands of the gp130-JAK/STAT3 signaling pathway, interleukin-6, leukemia inhibitory factor, and oncostatin M were elevated prior to activation of STAT3 and induction of astrogliosis; neuroprotection with nomifensine blocked these effects of MPTP. Taken together, our results suggest that the gp130-mediated activation of JAK2/STAT3 signaling pathway may play a key role in the induction of astrogliosis.

Received for publication, August 21, 2003 , and in revised form, March 1, 2004.

^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: HELD/TMBB, CDC-NIOSH, Mailstop L-3014, 1095 Willowdale Rd., Morgantown, WV 26505. Tel.: 304-285-6079; Fax: 304-285-6220; E-mail: jdo5{at}cdc.gov.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Beurel and R. S. Jope Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3 J. Biol. Chem., August 8, 2008; 283(32): 21934 - 21944. [Abstract] [Full Text] [PDF]

				J. E. Herrmann, T. Imura, B. Song, J. Qi, Y. Ao, T. K. Nguyen, R. A. Korsak, K. Takeda, S. Akira, and M. V. Sofroniew STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury J. Neurosci., July 9, 2008; 28(28): 7231 - 7243. [Abstract] [Full Text] [PDF]

				S. Bauer and P. H. Patterson Leukemia Inhibitory Factor Promotes Neural Stem Cell Self-Renewal in the Adult Brain. J. Neurosci., November 15, 2006; 26(46): 12089 - 12099. [Abstract] [Full Text] [PDF]

				C. Escartin, E. Brouillet, P. Gubellini, Y. Trioulier, C. Jacquard, C. Smadja, G. W. Knott, L. K.-L. Goff, N. Deglon, P. Hantraye, et al. Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo. J. Neurosci., May 31, 2006; 26(22): 5978 - 5989. [Abstract] [Full Text] [PDF]

				B. Emery, H. S. Cate, M. Marriott, T. Merson, M. D. Binder, C. Snell, P. Y. Soo, S. Murray, B. Croker, J.-G. Zhang, et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination PNAS, May 16, 2006; 103(20): 7859 - 7864. [Abstract] [Full Text] [PDF]

				S. Brahmachari, Y. K. Fung, and K. Pahan Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci., May 3, 2006; 26(18): 4930 - 4939. [Abstract] [Full Text] [PDF]

				K. Sriram, J. M. Matheson, S. A. Benkovic, D. B. Miller, M. I. Luster, and J. P. O'Callaghan Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-{alpha} FASEB J, April 1, 2006; 20(6): 670 - 682. [Abstract] [Full Text] [PDF]

				M. V. Sofroniew Reactive Astrocytes in Neural Repair and Protection Neuroscientist, October 1, 2005; 11(5): 400 - 407. [Abstract] [PDF]